Variant report
Variant | nsv946493 |
---|---|
Chromosome Location | chr1:168510865-168514616 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:305)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr1:168512256-168512493 | GM12878 | blood: | n/a | n/a |
2 | CTCF | chr1:168512268-168512339 | Kidney_OC | kidney: | n/a | n/a |
3 | CTCF | chr1:168511798-168511869 | Kidney_OC | kidney: | n/a | n/a |
4 | CTCF | chr1:168513517-168513676 | A549 | lung: | n/a | n/a |
5 | CTCF | chr1:168513062-168513142 | ProgFib | skin: | n/a | n/a |
6 | MYC | chr1:168513497-168513622 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr1:168513528-168513538 | MCF-7 | breast: | n/a | n/a |
8 | MYC | chr1:168513534-168513608 | MCF-7 | breast: | n/a | n/a |
9 | MYC | chr1:168513550-168513572 | MCF-7 | breast: | n/a | n/a |
10 | MYC | chr1:168513548-168513561 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr1:168513121-168513134 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr1:168513430-168513720 | A549 | lung: | n/a | n/a |
13 | POLR2A | chr1:168513463-168513667 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr1:168511527-168511528 | HepG2 | liver: | n/a | n/a |
15 | POLR2A | chr1:168511536-168511808 | HepG2 | liver: | n/a | n/a |
16 | POLR2A | chr1:168513517-168513645 | MCF-7 | breast: | n/a | n/a |
17 | POU2F2 | chr1:168513381-168513725 | GM12878 | blood: | n/a | n/a |
18 | SPI1 | chr1:168511755-168512021 | GM12878 | blood: | n/a | n/a |
19 | SPI1 | chr1:168511665-168512039 | GM12891 | blood: | n/a | n/a |
20 | SPI1 | chr1:168512143-168512577 | GM12891 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:168514108-168514158 | ProgFib | skin: | n/a |
2 | chr1:168513310-168513360 | ProgFib | skin: | n/a |
3 | chr1:168513310-168513360 | AG10803 | skin: | n/a |
4 | chr1:168513242-168513292 | HepG2 | liver: | n/a |
5 | chr1:168514108-168514158 | Caco-2 | colon: | n/a |
6 | chr1:168513242-168513292 | HCM | heart: | n/a |
7 | chr1:168513310-168513360 | HEK293 | kidney: | embryo |
8 | chr1:168513310-168513360 | A549 | lung: | n/a |
9 | chr1:168513242-168513292 | GM12878 | blood: | n/a |
10 | chr1:168513310-168513360 | HUVEC | blood vessel: | n/a |
11 | chr1:168513242-168513292 | SK-N-SH | brain: | n/a |
12 | chr1:168513067-168513117 | PrEC | prostate: | n/a |
13 | chr1:168514532-168514582 | U87 | brain: | n/a |
14 | chr1:168513067-168513117 | HAEpiC | amniotic membrane: | n/a |
15 | chr1:168513067-168513117 | BJ | skin: | n/a |
16 | chr1:168513242-168513292 | HEEpiC | esophagus: | n/a |
17 | chr1:168513242-168513292 | CMK | blood: | n/a |
18 | chr1:168514532-168514582 | RPTEC | kidney: | n/a |
19 | chr1:168514108-168514158 | Hela-S3 | cervix: | n/a |
20 | chr1:168513067-168513117 | AoSMC | blood vessel: | n/a |
21 | chr1:168513310-168513360 | T-47D | breast: | n/a |
22 | chr1:168513067-168513117 | LNCaP | prostate: | n/a |
23 | chr1:168514532-168514582 | HL-60 | blood: | n/a |
24 | chr1:168513067-168513117 | AG09309 | skin: | n/a |
25 | chr1:168513067-168513117 | HRE | kidney: | n/a |
26 | chr1:168514108-168514158 | SAEC | small airway: | n/a |
27 | chr1:168513067-168513117 | GM12892 | blood: | n/a |
28 | chr1:168513242-168513292 | BE2_C | brain: | n/a |
29 | chr1:168514108-168514158 | GM12891 | blood: | n/a |
30 | chr1:168513242-168513292 | U87 | brain: | n/a |
31 | chr1:168513067-168513117 | AG04450 | lung: | fetal |
32 | chr1:168513310-168513360 | NT2-D1 | testis: | n/a |
33 | chr1:168513310-168513360 | SKMC | muscle: | n/a |
34 | chr1:168513242-168513292 | Caco-2 | colon: | n/a |
35 | chr1:168513242-168513292 | AoSMC | blood vessel: | n/a |
36 | chr1:168514532-168514582 | HCPEpiC | choroid plexus: | n/a |
37 | chr1:168513067-168513117 | HL-60 | blood: | n/a |
38 | chr1:168513310-168513360 | GM12891 | blood: | n/a |
39 | chr1:168513242-168513292 | A549 | lung: | n/a |
40 | chr1:168513310-168513360 | GM12878 | blood: | n/a |
41 | chr1:168513242-168513292 | SKMC | muscle: | n/a |
42 | chr1:168513067-168513117 | Hela-S3 | cervix: | n/a |
43 | chr1:168513242-168513292 | HRPEpiC | eye: | n/a |
44 | chr1:168514108-168514158 | HIPEpiC | eye: | n/a |
45 | chr1:168514108-168514158 | U87 | brain: | n/a |
46 | chr1:168513067-168513117 | Jurkat | blood: | n/a |
47 | chr1:168513067-168513117 | MCF10A-Er-Src | breast: | n/a |
48 | chr1:168514532-168514582 | NT2-D1 | testis: | n/a |
49 | chr1:168514532-168514582 | HRE | kidney: | n/a |
50 | chr1:168513067-168513117 | HNPCEpiC | eye: | n/a |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-XCL2-3 | chr1:168514595-168514697 | l_145_NR_026957 |
2 | lnc-XCL2-3 | chr1:168514595-168514697 | NONHSAT007439 |
No data |
No data |
Variant related genes | Relation type |
---|---|
XCL2 | TF binding region |
ENSG00000227777 | TF binding region |
XCL2 | CpG island |
ENSG00000227777 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552840914 | chr1:168510876-168510877 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs570716980 | chr1:168510886-168510887 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535009794 | chr1:168510887-168510888 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184336771 | chr1:168510892-168510893 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187744852 | chr1:168510925-168510926 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535968452 | chr1:168510938-168510939 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149740232 | chr1:168510954-168510955 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576188088 | chr1:168510985-168510986 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543310970 | chr1:168510998-168510999 | Enhancers Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112789013 | chr1:168511037-168511038 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192656983 | chr1:168511058-168511059 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183575511 | chr1:168511059-168511060 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558955002 | chr1:168511077-168511078 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114737056 | chr1:168511081-168511082 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547905720 | chr1:168511110-168511111 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563687905 | chr1:168511119-168511120 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189568921 | chr1:168511137-168511138 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs76400946 | chr1:168511155-168511156 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571123469 | chr1:168511156-168511157 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377479708 | chr1:168511160-168511161 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528812710 | chr1:168511169-168511170 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372387492 | chr1:168511181-168511182 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377307734 | chr1:168511185-168511186 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115146581 | chr1:168511187-168511188 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114044923 | chr1:168511193-168511194 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376216377 | chr1:168511195-168511196 | Flanking Active TSS Weak transcription Active TSS Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116168093 | chr1:168511205-168511206 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370342820 | chr1:168511206-168511207 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201016321 | chr1:168511224-168511225 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
30 | rs375960253 | chr1:168511225-168511226 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370855359 | chr1:168511250-168511251 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
32 | rs374310854 | chr1:168511254-168511255 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
33 | rs145525833 | chr1:168511269-168511270 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537245270 | chr1:168511274-168511275 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558497766 | chr1:168511281-168511282 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4282797 | chr1:168511284-168511285 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs146927911 | chr1:168511292-168511293 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4501820 | chr1:168511321-168511322 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs4301615 | chr1:168511325-168511326 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs142896007 | chr1:168511331-168511332 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140039166 | chr1:168511337-168511338 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200963789 | chr1:168511346-168511347 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4478789 | chr1:168511349-168511350 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs541486301 | chr1:168511351-168511352 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371162931 | chr1:168511381-168511382 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
46 | rs199846581 | chr1:168511392-168511393 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530567551 | chr1:168511395-168511396 | Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
48 | rs654630 | chr1:168511412-168511413 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs145573734 | chr1:168511422-168511423 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528765532 | chr1:168511425-168511426 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:168506600-168511400 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
2 | chr1:168506600-168512400 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
3 | chr1:168507000-168512400 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
4 | chr1:168510200-168511200 | Genic enhancers | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr1:168510800-168511000 | Enhancers | Primary T cells fromperipheralblood | blood |
6 | chr1:168510800-168512600 | Active TSS | Primary T helper cells PMA-I stimulated | -- |
7 | chr1:168510800-168513000 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
8 | chr1:168511000-168511400 | Flanking Active TSS | Primary T cells fromperipheralblood | blood |
9 | chr1:168511200-168511400 | Transcr. at gene 5' and 3' | Primary Natural Killer cells fromperipheralblood | blood |
10 | chr1:168511400-168513000 | Active TSS | Primary T cells fromperipheralblood | blood |
11 | chr1:168511400-168513000 | Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
12 | chr1:168512400-168512600 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
13 | chr1:168512400-168513400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
14 | chr1:168512600-168513000 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
15 | chr1:168512600-168514400 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
16 | chr1:168513000-168513400 | Flanking Active TSS | Primary T cells fromperipheralblood | blood |
17 | chr1:168513000-168513400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
18 | chr1:168513000-168513400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
19 | chr1:168513000-168513400 | Flanking Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
20 | chr1:168513200-168513400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
21 | chr1:168513400-168514800 | Weak transcription | Primary T cells fromperipheralblood | blood |